Analyst Price Targets — NBP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 16, 2026 3:40 pm | Andres Maldonado | H.C. Wainwright | $9.00 | $2.86 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP) following FDA meeting feedback |
| October 27, 2025 10:53 am | Andrew Fein | H.C. Wainwright | $7.00 | $4.52 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on I-Mab (IMAB) |
| October 3, 2025 10:17 am | — | Leerink Partners | $9.00 | $4.13 | TheFly | I-Mab initiated with an Outperform at Leerink |
| September 10, 2025 5:29 pm | — | New Street | $7.00 | $4.18 | TheFly | BTIG says buy I-Mab amid 'misperceived' China risk |
| August 28, 2025 5:15 pm | Kumaraguru Raja | Loop Capital Markets | $8.00 | $4.25 | StreetInsider | I-Mab (IMAB) PT Raised to $8 at Brookline Capital Markets |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for NBP

ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that the Company's leadership will participate in the following investor conferences in September 2026: Conference…

NovaBridge Biosciences (NBP) Q2 2026 Earnings Call Transcript

ROCKVILLE, Md., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today reported financial results for the six months ended June 30, 2026, and provided a business update. During the first half of 2026,…

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that it will hold a webcast on Thursday, August 20, 2026 at 9:00 AM ET/9:00 PM China Standard Time to discuss recent…

Woodside Energy Group (ASX: WDS) (NYSE: WDS):2026 full-year guidancePriorCurrentTotal production volumes3MMboe172-186174-185Gas hub exposure4%~30No changeCapita
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NBP.
U.S. House Trading
No House trades found for NBP.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
